<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00738933</url>
  </required_header>
  <id_info>
    <org_study_id>231857</org_study_id>
    <nct_id>NCT00738933</nct_id>
  </id_info>
  <brief_title>Dietary Phytosterols and Human Aortic Valve</brief_title>
  <official_title>Effects of Dietary Plant Sterols and Stanols on Sterol Composition and Structure of the Human Aortic Valve</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Eastern Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Helsinki University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled double-blind intervention study unravels influence of dietary
      plant sterols and stanols on the structure and the sterol composition of the human aortic
      valve. The study patients will include 50-60 voluntary patients from the Helsinki Univ.
      Central Hospital, who will undergo aortic valve surgery. The patients will be randomized into
      plant sterol (E), plant stanol (A) and control (C) groups. Patients in the E and A groups
      will be asked to consume daily 2 grams plant sterols or plant stanols, respectively, in a
      margarine product.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High level of serum cholesterol is a risk factor for atherosclerotic complications, including
      atherosclerotic aortic valve disease. Over 50 years dietary plant sterols have been used to
      inhibit intestinal cholesterol absorption and to decrease its levels in serum. Daily human
      diet contains numerous different plant sterols, of which sitosterol and campesterol are the
      most abundant ones. Few epidemiologic studies suggest that sitosterol and campesterol may
      also be involved in formation of atherosclerotic changes in human arteries. The saturated
      forms of sitosterol and campesterol, i.e., the plant stanols (mainly sitostanol and
      campestanol) are beneficial with this respect. As part of daily diet, the plant stanols
      decrease absorption of both cholesterol and plant sterols, and thus, are putatively even more
      effective in prevention of atherosclerosis than the respective plant sterols.

      Our double-blind controlled intervention study unravels influence of dietary plant sterols
      and stanols on the structure and the sterol composition of the human aortic valve.

      50-60 patients, who will undergo aortic valve surgery, will be asked to volunteer our study.
      The patients will be randomized into three groups: (A) a group consuming margarine containing
      daily 2 grams plant stanols, (E) a group consuming margarine containing daily 2 grams of
      plant sterols, (C) a control group consuming margarine without any plant sterols or stanols.
      The dietary intervention will last for 4 to 8 weeks from the randomization to the operation.

      Serum samples for analyses of serum lipids, lipoproteins and sterols will be collected at the
      randomization and at the operation. The atherosclerotic aortic valve will be examined with
      respect to its composition of cholesterol, other sterols and stanols.

      The aim of our study is to elucidate the effects of dietary consumption of plant sterols and
      stanols on the sterol composition and structure of the atherosclerotic disease-affected
      aortic valve in human patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2008</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composition of serum and aortic valve sterols at the time of aortic valve operation</measure>
    <time_frame>Up to 4 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hypercholesterolemia</condition>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A group of patients consuming 2 grams plant stanols 4-8 weeks before the operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>E</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A group of patients consuming daily 2 grams plant sterols 4-8 weeks before the operation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dietary plant stanols</intervention_name>
    <description>Daily 2 grams of plant stanols in a margarine preparation for 4-8 weeks before the operation</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dietary plant sterols</intervention_name>
    <description>Daily 2 grams of plant sterols in a margarine preparation for 4-8 weeks before the operation</description>
    <arm_group_label>E</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Margarine product without plant stanol or sterol esters</description>
    <arm_group_label>C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Atherosclerotic aortic valve disease needing an aortic valve replacement operation

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tatu A. Miettinen, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Medicine, Div. of Internal Medicine, Helsinki Univ. Central Hospital, Biomedicum Helsinki</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Helena Gylling, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Nutrition, University of Kuopio and Kuopion University Central Hospital, Kuopio, Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markku J Nissinen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Medicine, Div. of Gastroenterology, HUCH, Helsinki, Finland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Markku J. Nissinen, MD, PhD</last_name>
    <phone>+358 9 4711</phone>
    <email>markku.nissinen@hus.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Medicine, Div. of Internal Medicine, Helsinki Univ. Central Hospital (HUCH)</name>
      <address>
        <city>Helsinki</city>
        <zip>00029HUS</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markku Nissinen, MD, PhD</last_name>
      <phone>+358 9 4711</phone>
      <email>markku.nissinen@hus.fi</email>
    </contact>
    <investigator>
      <last_name>Tatu A Miettinen, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Markku J Nissinen, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2008</study_first_submitted>
  <study_first_submitted_qc>August 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2008</study_first_posted>
  <last_update_submitted>February 11, 2011</last_update_submitted>
  <last_update_submitted_qc>February 11, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 14, 2011</last_update_posted>
  <responsible_party>
    <name_title>Markku Nissinen, MD PhD</name_title>
    <organization>Helsinki University Central Hospital</organization>
  </responsible_party>
  <keyword>Atherosclerosis</keyword>
  <keyword>Plant sterols</keyword>
  <keyword>Plant stanols</keyword>
  <keyword>Aortic valve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

